» Articles » PMID: 23928666

Changes in Circulating MicroRNAs Are Associated with Childhood Obesity

Overview
Specialty Endocrinology
Date 2013 Aug 10
PMID 23928666
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Circulating microRNAs (miRNAs) are valuable biomarkers of metabolic diseases and potential therapeutic targets in this field.

Objective: Our objective was to define the circulating pattern of miRNAs in childhood obesity. DESIGN, SETTINGS, AND MAIN OUTCOME MEASURE: The genome-wide circulating miRNA profile was assessed by RT-PCR in 10 boys (5 lean and 5 obese children). The most relevant miRNAs were cross-sectionally validated in 85 lean versus 40 obese children (63 boys and 62 girls) and longitudinally evaluated in samples from the same children when they were ≈ 7 and ≈ 10 years old (23 boys and 22 girls).

Results: The cross-sectional validation study disclosed that 15 specific circulating miRNAs were significantly deregulated in prepubertal obesity, including the decreased miR-221 and miR-28-3p and increased concentrations in plasma of miR-486-5p, miR-486-3p, miR-142-3p, miR-130b, and miR-423-5p (all P < .0001). The circulating concentration of these miRNAs was significantly associated with body mass index and other measures of obesity such as percent fat mass, waist, regional fat distribution and with laboratory parameters such as homeostasis model assessment of insulin resistance, high-molecular-weight adiponectin, C-reactive protein, and circulating lipids in concordance with anthropometric associations. Plasma concentrations of 10 of these circulating miRNAs changed significantly and differently during the 3-year follow-up in children who increased or decreased their normalized weight.

Conclusion: This study provides the first evidence that circulating miRNAs are deregulated in prepubertal obese children. Thus, the very early detection of an abnormal circulating miRNA profile may be a promising strategy to identify obese children who may suffer from metabolic abnormalities.

Citing Articles

MicroRNAs as Epigenetic Regulators of Obesity.

Engin A, Engin A Adv Exp Med Biol. 2024; 1460:595-627.

PMID: 39287866 DOI: 10.1007/978-3-031-63657-8_20.


Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population.

Weale C, Schroeder C, Matshazi D, Davids S, Erasmus R, Kengne A J Diabetes Investig. 2024; 15(10):1377-1389.

PMID: 39087408 PMC: 11442782. DOI: 10.1111/jdi.14278.


A review on cell-free RNA profiling: Insights into metabolic diseases and predictive value for bariatric surgery outcomes.

Mareboina M, Deng E, Mouratidis I, Yee N, Pitteloud N, Georgakopoulos-Soares I Mol Metab. 2024; 87:101987.

PMID: 38977131 PMC: 11305000. DOI: 10.1016/j.molmet.2024.101987.


Therapeutic Impact of Aerobic Exercise on Adolescents with Obesity and Its Association with Expression of miRNAs and Cytokines: A Clinical Approach.

Hillari Raj P, Subramanian P, Nehru M, Ayyavoo S, Annamalai N, Prabhu V Medicina (Kaunas). 2024; 60(3).

PMID: 38541185 PMC: 10972348. DOI: 10.3390/medicina60030459.


Tissue and Circulating MicroRNAs 378 and 142 as Biomarkers of Obesity and Its Treatment Response.

Matveev G, Khromova N, Zasypkin G, Kononova Y, Vasilyeva E, Babenko A Int J Mol Sci. 2023; 24(17).

PMID: 37686231 PMC: 10487855. DOI: 10.3390/ijms241713426.